Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

Eitemau Tebyg

• Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
  gan: Niewald Marcus, et al.
  Cyhoeddwyd: (2011-10-01)
• Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
  gan: Victor Lewitzki, et al.
  Cyhoeddwyd: (2019-12-01)
• Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
  gan: Gademann Guenther, et al.
  Cyhoeddwyd: (2010-10-01)
• Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
  gan: Unterberg Andreas, et al.
  Cyhoeddwyd: (2010-11-01)
• Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
  gan: Emilie Thivat, et al.
  Cyhoeddwyd: (2023-04-01)